Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB

Spalinger, Marianne, Hai, Rong, Li, Jiang, Nordgren, Tara M.; Tremblay, Michel L.; Eckmann, Lars, Hanson, Elaine M.; Scharl, Michael M.; Wu, Xiwei, Boland, Brigid, McCole, Declan F.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB

Spalinger, Marianne, Hai, Rong, Li, Jiang, Nordgren, Tara M.; Tremblay, Michel L.; Eckmann, Lars, Hanson, Elaine M.; Scharl, Michael M.; Wu, Xiwei, Boland, Brigid, McCole, Declan F..

Gastroenterology ; 160(6):S-430, 2021.

Article in English | PMC | ID: covidwho-1386778

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: PMC Type of study: Prognostic study Topics: Variants Language: English Journal: Gastroenterology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: PMC Type of study: Prognostic study Topics: Variants Language: English Journal: Gastroenterology Year: 2021 Document Type: Article